State Street Health Care Select Sector SPDR ETF (XLV)
An exchange-traded fund listed on AMEX. A fund is not a company: it has no filed accounts of its own here, and it is never ranked beside companies. Every figure below is market data, with the day it was supplied.
Price
Last close 177.19 USD on Oct 15, 2026. Market data, supplied Oct 15, 2026.
What it costs
| Expense ratio | 0.08% |
| Assets under management | 43.92B USD |
| Net asset value per share | 169.68 USD |
| Inception | Dec 16, 1998 |
| Sponsor | SPDR |
| Asset class | Equity |
| Holdings the fund reports | 61 |
Market data, supplied Oct 15, 2026.
What it holds
The largest 25 by weight of the 64 holdings in the snapshot of Oct 15, 2026. A fund is marked as a fund, and a holding that is not a company's share (a bond, a bill, cash, an option or a swap) is marked as not a company.
| # | Holding | Weight |
|---|---|---|
| 1 | ELI LILLY + CO | 15.33% |
| 2 | JOHNSON + JOHNSON | 9.70% |
| 3 | ABBVIE INC | 7.89% |
| 4 | MERCK + CO. INC. | 5.76% |
| 5 | UNITEDHEALTH GROUP INC | 5.63% |
| 6 | THERMO FISHER SCIENTIFIC INC | 3.94% |
| 7 | AMGEN INC | 3.65% |
| 8 | GILEAD SCIENCES INC | 3.02% |
| 9 | ABBOTT LABORATORIES | 2.81% |
| 10 | PFIZER INC | 2.64% |
| 11 | INTUITIVE SURGICAL INC | 2.35% |
| 12 | DANAHER CORP | 2.23% |
| 13 | VERTEX PHARMACEUTICALS INC | 2.00% |
| 14 | BRISTOL MYERS SQUIBB CO | 1.92% |
| 15 | CVS HEALTH CORP | 1.83% |
| 16 | MEDTRONIC PLC | 1.83% |
| 17 | MCKESSON CORP | 1.80% |
| 18 | STRYKER CORP | 1.56% |
| 19 | ELEVANCE HEALTH INC | 1.47% |
| 20 | MODERNA INC | 1.33% |
| 21 | THE CIGNA GROUP | 1.21% |
| 22 | REGENERON PHARMACEUTICALS | 1.21% |
| 23 | HCA HEALTHCARE INC | 1.10% |
| 24 | CENCORA INC | 1.02% |
| 25 | BOSTON SCIENTIFIC CORP | 0.99% |
Market data, supplied Oct 15, 2026.
Sector weights
| Healthcare | 99.06% |
| Technology | 0.70% |
| Cash & Others | 0.24% |
Market data, supplied Oct 15, 2026.
Country weights
| United States | 97.76% |
| Ireland | 2.22% |
| Other | 0.01% |
Market data, supplied Oct 15, 2026.
Look-through value
Earnings yield, P/E and book yield of the holdings taken together: n/a. Look-through figures are not measured for this fund yet.